全文获取类型
收费全文 | 3097篇 |
免费 | 248篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 22篇 |
儿科学 | 53篇 |
妇产科学 | 56篇 |
基础医学 | 344篇 |
口腔科学 | 63篇 |
临床医学 | 367篇 |
内科学 | 674篇 |
皮肤病学 | 154篇 |
神经病学 | 171篇 |
特种医学 | 124篇 |
外科学 | 498篇 |
综合类 | 7篇 |
预防医学 | 99篇 |
眼科学 | 19篇 |
药学 | 316篇 |
中国医学 | 4篇 |
肿瘤学 | 385篇 |
出版年
2023年 | 31篇 |
2022年 | 37篇 |
2021年 | 64篇 |
2020年 | 41篇 |
2019年 | 44篇 |
2018年 | 66篇 |
2017年 | 55篇 |
2016年 | 42篇 |
2015年 | 57篇 |
2014年 | 81篇 |
2013年 | 109篇 |
2012年 | 164篇 |
2011年 | 180篇 |
2010年 | 116篇 |
2009年 | 95篇 |
2008年 | 154篇 |
2007年 | 165篇 |
2006年 | 164篇 |
2005年 | 159篇 |
2004年 | 168篇 |
2003年 | 148篇 |
2002年 | 142篇 |
2001年 | 73篇 |
2000年 | 89篇 |
1999年 | 96篇 |
1998年 | 36篇 |
1997年 | 28篇 |
1996年 | 29篇 |
1995年 | 29篇 |
1994年 | 20篇 |
1992年 | 34篇 |
1991年 | 47篇 |
1990年 | 49篇 |
1989年 | 44篇 |
1988年 | 47篇 |
1987年 | 49篇 |
1986年 | 53篇 |
1985年 | 59篇 |
1984年 | 36篇 |
1983年 | 22篇 |
1982年 | 17篇 |
1981年 | 18篇 |
1980年 | 24篇 |
1979年 | 25篇 |
1978年 | 15篇 |
1977年 | 16篇 |
1974年 | 17篇 |
1973年 | 19篇 |
1971年 | 12篇 |
1966年 | 11篇 |
排序方式: 共有3356条查询结果,搜索用时 15 毫秒
101.
H. Fukushima T. Mitsuhashi T. Oto Y. Sano K. F. Kusano K. Goto M. Okazaki H. Date Y. Kojima H. Yamagishi T. Takahashi 《American journal of transplantation》2013,13(12):3278-3281
Diffuse pulmonary arteriovenous malformations (AVMs) are associated with a poor prognosis and the therapeutic strategy remains controversial. We describe a pediatric patient with diffuse pulmonary AVMs associated with hereditary hemorrhagic telangiectasia (HHT), who presented with two cerebral AVMs in the parietal and occipital lobes as well. Of note, successful bilateral lung transplantation not only improved the hypoxemia but also resulted in size reduction of the cerebral AVMs. Although it is essential to consider involvements other than pulmonary AVMs, especially brain AVMs, to decide the indication, lung transplantation can be a viable therapeutic option for patients with diffuse pulmonary AVMs and HHT. 相似文献
102.
103.
Trials of vaccines for pancreatic ductal adenocarcinoma: Is there any hope of an improved prognosis?
Toru?MizuguchiEmail author Toshihiko?Torigoe Fukino?Satomi Hiroaki?Shima Goro?Kutomi Shigenori?Ota Masayuki?Ishii Hiroshi?Hayashi Sumiyo?Asakura Yoshihiko?Hirohashi Makoto?Meguro Yasutoshi?Kimura Toshihiko?Nishidate Kenji?Okita Masaho?Ishino Atsushi?Miyamoto Masamitsu?Hatakenaka Noriyuki?Sato Koichi?Hirata 《Surgery today》2016,46(2):139-148
Pancreatic tumors are chemoresistant and malignant, and there are very few therapeutic options for pancreatic cancer, as the disease is normally diagnosed at an advanced stage. Although attempts have been made to develop vaccine therapies for pancreatic cancer for a couple of decades, none of the resultant protocols or regimens have succeeded in improving the clinical outcomes of patients. We herein review vaccines tested within the past few years, including peptide, biological and multiple vaccines, and describe the three sets of criteria used to evaluate the therapeutic activity of vaccines in solid tumors. 相似文献
104.
Michio Kuwahara Youhei Arai Eriko Takehara Yasunori Sasaki Tomoharu Yoshimine Keita Kusaka Satomi Shikuma Wataru Akita Shinichi Uchida 《Clinical and experimental nephrology》2016,20(4):585-594
Background
Renal anemia complicated with chronic kidney disease is usually treated with erythropoiesis-stimulating agents (ESAs). However, few studies have compared the early response of hemoglobin (Hb) to different kinds of ESAs.Methods
The effects of three types of ESAs—epoetin alfa or beta (EPO), darbepoetin alfa (DPO), and epoetin beta pegol (EPObp)—on renal anemia were followed in 416 pre-dialysis chronic kidney disease (CKD) patients. After the initial 12-week administration of ESAs, ΔHb/ESA dose/kg was calculated as an index of efficacy of each ESA. Furthermore, independent variables associated with ΔHb/ESA dose/kg (dependent variable) were determined using multiple linear regression analysis. The ten independent variables selected for analysis were: presence of diabetic nephropathy, estimated glomerular filtration rate (eGFR), Hb, albumin, iron (Fe), transferrin saturation (TSAT), ferritin, phosphate (P), intact parathyroid hormone (iPTH), and C-reactive protein.Results
The efficacy of DPO and EPObp were similar and higher than EPO. TSAT was most strongly correlated with ΔHb/EPO dose/kg in all three types of ESAs. Other significant independent factors were Hb, albumin, P, iPTH, and diabetic nephropathy in the EPO group, eGFR in the DPO group, and Fe in the EPObp group. The adjusted coefficient of determination (R 2) ranged from 0.415 to 0.520 in the three ESA groups.Conclusions
The study results suggest that TSAT is the best predictor of the initial 12-week responsiveness to ESA, irrespective of the type. Variables not investigated in this study also affect responsiveness to ESA in Japanese pre-dialysis CKD patients.105.
Satomi Omotehara Mutsumi Nishida Megumi Satoh Mamiko Inoue Yusuke Kudoh Tatsunori Horie Akihiro Homma Yuji Nakamaru Kanako C. Hatanaka Chikara Shimizu 《Journal of Medical Ultrasonics》2016,43(2):257-262
Purpose
We evaluated the sonographic findings of immunoglobulin G4-related sclerosing sialadenitis (IgG4-SS).Methods
Nineteen patients with IgG4-SS and 12 healthy volunteers (controls) were enrolled. The following sonographic features were evaluated: (1) enlargement of the submandibular gland by measurement of the longitudinal diameter and thickness; (2) the contour texture of the submandibular gland (smooth or rough); (3) the internal echo texture, categorized into three sonographic patterns (homogeneous, multiple hypoechoic nodule, and diffuse hypoechoic); and (4) quantitative color Doppler signaling.Results
The longitudinal diameter and the thickness (mean ± SD) of the submandibular gland were significantly greater in patients than in controls (p = 0.005 and p < 0.001, respectively). Contour roughness was seen in 62.9 and 8.3 % of patients and controls (p < 0.001), respectively. Homogeneous echo textures alone were seen in controls, whereas multiple hypoechoic nodule patterns were seen in 60 % of the patients, and diffuse hypoechoic patterns were seen in 40 %. Color Doppler signaling (mean ± SD) was significantly higher in patients as compared with controls (p < 0.001).Conclusion
Patients could be distinguished from healthy volunteers using four distinctive sonographic findings, suggesting that ultrasonography would be a useful diagnostic tool for IgG4-SS.106.
Matsuura K Tanaka Y Takagi K Hiramatsu K Kani S Gotoh T Wakimoto Y Joh T Mizokami M 《Rinsho byori. The Japanese journal of clinical pathology》2007,55(11):983-988
The Abbott Real Time HCV assay (lower limit of detection 12 IU/ml) was developed as a highly sensitive HCV RNA quantitative assay using real-time detection PCR(RTD-PCR). We assessed whether the new assay more effectively predicts sustained virological response (SVR) than conventional PCR (PCR) in 38 chronic hepatitis patients infected with HCV genotype 1b and treated with pegylated interferon alpha2b plus ribavirin. Sixteen patients reached SVR, 10 patients relapsed, 9 patients did not respond, 3 patients discontinued treatment. Positive predictive value (PPV) for SVR of undetectable HCV RNA at W4, 8, 12 by RTD-PCR and PCR was (100% vs. 100% at W4), (100% vs. 100% at W8), (83.3% vs. 72.7% at W12). HCV RNA undetectable at W12 had a higher PPV for SVR when measured by RTD-PCR than by conventional PCR. 相似文献
107.
108.
Development of a novel ELISA for detection of anti-A and anti-B antibodies in recipients of ABO-incompatible living donor liver grafts 总被引:1,自引:0,他引:1
Satoh A Kawagishi N Minegishi M Takahashi H Akamatsu Y Doi H Satomi S 《The Tohoku journal of experimental medicine》2007,211(4):359-367
The survival rate in ABO-incompatible (ABO-I) liver transplantation was much lower than that in ABO-compatible recipients for the early experiences. It is therefore essential to develop the precise and fast measurement of anti-A and anti-B antibodies (Abs) to prevent humoral rejection in ABO-I liver transplantation. Agglutination titer has been the standard method to measure these Abs, but the interpretation of the results is subject to bias. Here, we have developed an objective and quantitative enzyme-linked immunosorbent assay (ELISA) to measure anti-A and anti-B Abs. This test requires only a small amount (10 microl) of recipient's serum. We applied the newly developed ELISA to monitor living donor liver transplant recipients and investigated the correlation between ELISA and agglutination titer. The Spearman's correlation coefficient for Abs ranged from 0.461 to 0.812. Moreover, in one case of humoral rejection, the increase of Abs was detected by ELISA one day earlier than by the agglutination titer. In conclusion, our ELISA method proved useful to detect an increase of anti-A and anti-B Abs titers at an early stage, thereby contributing to a prompt treatment of humoral rejection due to ABO-I. 相似文献
109.
Tsuyoshi Ozawa MD Shinsuke Kazama MD PhD Takashi Akiyoshi MD PhD Koji Murono MD Satomi Yoneyama MD PhD Toshiaki Tanaka MD PhD Junichiro Tanaka MD PhD Tomomichi Kiyomatsu MD PhD Kazushige Kawai MD PhD Hiroaki Nozawa MD PhD Takamitsu Kanazawa MD PhD Hironori Yamaguchi MD PhD Soichiro Ishihara MD PhD Eiji Sunami MD PhD Joji Kitayama MD PhD Teppei Morikawa MD PhD Masashi Fukayama MD PhD Toshiaki Watanabe MD PhD 《Annals of surgical oncology》2014,21(8):2650-2658
Background
The importance of Notch signaling in colorectal cancer (CRC) tumorigenesis has been recently recognized. However, the significance of Notch3 expression and its association with Notch1 expression in CRC is unclear. In the present study, we investigated Notch1 and Notch3 expression in Stage II and III CRC to assess their association with clinicopathological characteristics.Methods
The protein expression of Notch1 and Notch3 was examined using immunohistochemistry in 305 CRC specimens. Nuclear expression of Notch1 and Notch3 and their associations with clinicopathological characteristics and distant relapse-free survival (dRFS) were evaluated.Results
Nuclear Notch1 was overexpressed in 37 % of specimen, and nuclear Notch3 in 38 %. Nuclear Notch3 expression correlated with tumor differentiation status (P = 0.0099). Nuclear expression of Notch1 and Notch3 was associated with tumor recurrence (P = 0.0311 and P = 0.0053, respectively). In multivariate analysis, nuclear Notch3 expression [hazard ratio (HR) = 1.71; 95 % confidence interval (CI), 1.06–2.78; P = 0.0271), lymph node metastasis, and venous involvement were independently correlated with dRFS. In subgroup analysis, nuclear Notch3 expression was strongly associated with dRFS in Stage II CRC (HR = 3.47; 95 % CI 1.44–9.22; P = 0.0055). Both nuclear Notch1 and Notch3 were positive in 67 specimens (22 %) and both were negative in 144 specimens (47 %). Coexpression of nuclear Notch1 and Notch3 had an additive effect toward poorer dRFS compared with a negative subtype (HR = 2.48; 95 % CI, 1.41–4.40; P = 0.0019).Conclusions
Nuclear Notch3 expression might be a novel predictive marker for recurrence in Stage II and III CRC. 相似文献110.
Michio Kuwahara Syoko Hasumi Shintaro Mandai Tomomi Tanaka Satomi Shikuma Wataru Akita Yoshihiro Mori Sei Sasaki 《Clinical and experimental nephrology》2014,18(5):755-762